Overview of vaccines for adults authorized, recommended, and implemented in the European Union

Affiliations

¹ Centre for the Evaluation of Vaccination (CEV), University of Antwerp, Antwerp, Belgium. Jade.Pattyn@uantwerpen.be.
² Université Paris Cité; Insern, CIC1417, F-CRIN, I -REIVAC; Asssistance-Publique-Hopitaux de Paris, Hôpital Cochin, Paris, France.
³ Epidemiology, Biostatistics and Prevention Institute, Department of Public and Global Health, Division of Infectious Diseases, World Health Organization Collaborating Centre for Travelers' Health, University of Zurich, Zurich, Switzerland.
⁴ Institute for Biomedical Aging Research, Universität Innsbruck, Innsbruck, Austria.
⁵ Working Group Vaccines and Immunization Policies, Italian Society of Hygiene, Preventive Medicine and Public Health, Cogorno, Italy.
⁶ Institute of Microbiology and Immunology, Medical faculty, University Ljubljana, Ljubljana, Slovenia.
⁷ Ernst von Bergmann Hospital, Potsdam, Germany.
⁸ Clinic of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
⁹ Department of Health Sciences; University of Florence, Florence, Italy.
¹⁰ Centre for the Evaluation of Vaccination (CEV), University of Antwerp, Antwerp, Belgium.

PMID: 40760062
PMCID: PMC12322272
DOI: 10.1038/s41541-025-01242-6

Overview of vaccines for adults authorized, recommended, and implemented in the European Union

Jade Pattyn et al. NPJ Vaccines. 2025.

. 2025 Aug 4;10(1):183.

doi: 10.1038/s41541-025-01242-6.

Authors

Affiliations

¹ Centre for the Evaluation of Vaccination (CEV), University of Antwerp, Antwerp, Belgium. Jade.Pattyn@uantwerpen.be.
² Université Paris Cité; Insern, CIC1417, F-CRIN, I -REIVAC; Asssistance-Publique-Hopitaux de Paris, Hôpital Cochin, Paris, France.
³ Epidemiology, Biostatistics and Prevention Institute, Department of Public and Global Health, Division of Infectious Diseases, World Health Organization Collaborating Centre for Travelers' Health, University of Zurich, Zurich, Switzerland.
⁴ Institute for Biomedical Aging Research, Universität Innsbruck, Innsbruck, Austria.
⁵ Working Group Vaccines and Immunization Policies, Italian Society of Hygiene, Preventive Medicine and Public Health, Cogorno, Italy.
⁶ Institute of Microbiology and Immunology, Medical faculty, University Ljubljana, Ljubljana, Slovenia.
⁷ Ernst von Bergmann Hospital, Potsdam, Germany.
⁸ Clinic of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
⁹ Department of Health Sciences; University of Florence, Florence, Italy.
¹⁰ Centre for the Evaluation of Vaccination (CEV), University of Antwerp, Antwerp, Belgium.

PMID: 40760062
PMCID: PMC12322272
DOI: 10.1038/s41541-025-01242-6

Erratum in

Author Correction: Overview of vaccines for adults authorized, recommended, and implemented in the European Union.
Pattyn J, Launay O, Steffen R, Weinberger B, Gabutti G, Ihan A, Weinke T, Jancoriene L, Bonanni P, Van Damme P. Pattyn J, et al. NPJ Vaccines. 2025 Aug 28;10(1):205. doi: 10.1038/s41541-025-01257-z. NPJ Vaccines. 2025. PMID: 40877348 Free PMC article. No abstract available.

Abstract

An increasing number of vaccines for adults are being implemented in vaccination programs, reflecting the growing recognition of immunization as a lifelong public health strategy. However, no comprehensive overview of all vaccines for adults authorized, recommended, and implemented in the EU currently exists. To address this, the Adult Immunization Board developed a “vaccines for adults tracker and landscape” to map the range of vaccines for adults approved across the EU.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

References

1. Cassimos, D. C. et al. Vaccination programs for adults in Europe, 2019. Vaccines8, 34 (2020). - PMC - PubMed
1. Jones, C. H. et al. Exploring the future adult vaccine landscape-crowded schedules and new dynamics. NPJ Vaccines9, 27 (2024). - PMC - PubMed
1. World Health Organization. Global vaccine market report 2024. (WHO, 2024).
1. Pattyn, J. et al. The Adult Immunization Board (AIB): a new platform to provide multidisciplinary guidelines for the implementation and optimization of adult immunization in Europe. Vaccine42, 1–3 (2024). - PubMed
1. Pattyn, J. & Bonanni, P. Assessing the health burden of vaccine-preventable infections in European adults: challenges and opportunities translated into action. Eur. Surveill.28, 2300791 (2023). - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Overview of vaccines for adults authorized, recommended, and implemented in the European Union

Affiliations

Overview of vaccines for adults authorized, recommended, and implemented in the European Union

Authors

Affiliations

Erratum in

Abstract

Conflict of interest statement

References

Publication types

LinkOut - more resources

Full Text Sources